Egholm Michael (CIK 1559779) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-22). Recent activity: Sell LAB (97,626 shares), Buy LAB (1.0M shares), Buy LAB (196,513 shares), Sell LAB (95,014 shares), Sell LAB (66,127 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-22 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 97,626 | $97,626 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Buy | 1.0M | $0 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Buy | 196,513 | $0 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 95,014 | $86,273 |
| 2026-02-24 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 66,127 | $76,046 |
| 2025-11-24 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 63,529 | $81,317 |
| 2025-08-22 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 54,919 | $69,747 |
| 2025-08-05 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Buy | 3.0M | $0 |
| 2025-05-30 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 9,906 | $10,798 |
| 2025-05-28 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 5,473 | $5,145 |
| 2025-05-27 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 5,116 | $5,116 |
| 2025-05-22 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 18,343 | $19,260 |
| 2025-05-22 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 4,719 | $4,861 |
| 2025-04-08 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Buy | 196,512 | $0 |
| 2025-04-08 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 57,676 | $61,713 |
| 2025-03-24 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Buy | 1.2M | $0 |
| 2025-02-24 | STANDARD BIOTOOLS INC. (LAB) | President & CEO | Sell | 31,031 | $43,133 |
Source: SEC Form 4 filings · as of 2026-05-22